Skip to main content

Debbane Raymond

In the past year, 5 open-market purchase filings worth $2.72M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$2.72M
5 filings
Sold
–
0 filings
Net
+$2.72M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Debbane Raymond as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

LXRX Lexicon Pharmaceuticals, Inc.

Director9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 27, 2026 (view filing)Feb 252 daysDebbane RaymondDirectorPPurchase+2.00K$1.49+$2.98K+0.1%1.91M after
Feb 25, 2026 (view filing)Feb 232 daysDebbane RaymondDirectorPPurchase+100.0K$1.47+$147.0K+5.5%1.90M after
Feb 23, 2026 (view filing)Feb 19-204 daysDebbane RaymondDirectorPPurchase+150.0K$1.47+$220.0K+9.1%1.80M after2 lots
Feb 18, 2026 (view filing)Feb 13-185 daysDebbane RaymondDirectorPPurchase+268.5K$1.31+$353.1K+19.4%1.65M after3 lots
Feb 4, 2026 (view filing)4:25 PM ETFeb 22 daysDebbane Raymond and 8 othersDirectorPPurchase+1.54M$1.30+$2.00MNew position1.54M after
Oct 12, 2023 (view filing)Oct 10-122 daysDebbane RaymondDirectorPPurchase+1.00M$1.10+$1.10M+293.4%1.34M after3 lots
Aug 9, 2022 (view filing)4:48 PM ETAug 54 daysDebbane Raymond and 2 othersDirector, 10% OwnerPPurchase+147.4K$2.50+$368.5K+2.8%5.45M after
Aug 1, 2022 (view filing)4:15 PM ETAug 1Same dayDebbane Raymond and 2 othersDirector, 10% OwnerPPurchase+982.6K$2.50+$2.46M+22.7%5.30M afterDuplicate filing
Aug 1, 2022 (view filing)Aug 1Same dayDebbane RaymondDirectorPPurchase+982.6K$2.50+$2.46M+22.7%5.30M after

SRRK Scholar Rock Holding Corp

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 12, 2024 (view filing)4:39 PM ETDec 102 daysDebbane Raymond and 4 others10% OwnerSSale−1.60M$41.65−$66.6M−14.7%9.25M after
Nov 27, 2024 (view filing)4:31 PM ETNov 252 daysDebbane Raymond and 4 others10% OwnerSSale−409.4K$38.49−$15.8M−3.6%10.9M after5 lots

CBIO Crescent Biopharma, Inc.

10% Owner4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 9, 2024 (view filing)4:30 PM ETAug 7-82 daysDebbane Raymond and 4 others10% OwnerSSale−322.4K$0.1899−$61.2K−4.9%6.32M after2 lots
Aug 7, 2024 (view filing)4:30 PM ETAug 5-62 daysDebbane Raymond and 4 others10% OwnerSSale−220.3K$0.187−$41.2K−3.2%6.64M after2 lots
Aug 5, 2024 (view filing)4:53 PM ETAug 1-24 daysDebbane Raymond and 4 others10% OwnerSSale−349.8K$0.2033−$71.1K−4.9%6.86M after2 lots
Jul 30, 2024 (view filing)5:16 PM ETJul 26-304 daysDebbane Raymond and 4 others10% OwnerSSale−1.38M$0.2286−$315.3K−16.1%7.21M after3 lots

WW WW International, Inc.

Other: Former Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 15, 2022 (view filing)Nov 105 daysDebbane RaymondDirectorPPurchase+75.0K$4.27+$320.3K+145.8%126.4K after